MANÜ Telehealth Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: adding NAD+, sermorelin or MIC injections to a compounded GLP-1 from one seller
MANÜ Telehealth scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $199 a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Compounded semaglutide plans start at $199 and tirzepatide plans at $297, well above the $4 to $5 a day the homepage advertises. MANÜ Telehealth sells compounded weight loss medication, injectable tirzepatide and semaglutide, with MIC Ultraburn and NAD+ injections offered as add-ons; US 503A pharmacies do the compounding. The process is fully online, with free shipping and no insurance required. Compounded medications here are not FDA-evaluated.
Is MANÜ Telehealth legit?
Yes. MANÜ Telehealth is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.3/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a MANÜ Telehealth promo or coupon code?
We know of no promo or coupon code for MANÜ Telehealth. Its listed price is $199 a month. Coupon sites advertising "MANÜ Telehealth discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how MANÜ Telehealth compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to MANÜ Telehealth
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
MANÜ Telehealth at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Compounded tirzepatide, Compounded semaglutide
- Starting price
- $199/mo
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How MANÜ Telehealth scores
Six columns, each one computed from something MANÜ Telehealth has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.0/10The listed figure is not a comparable monthly price for a named GLP-1 (it may be a membership fee, an insured copay, a per-vial rate or a starting-dose price), so Value is capped rather than scored against other sellers.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on MANÜ Telehealth
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for MANÜ Telehealth
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with MANÜ Telehealth involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1MANÜ Telehealth shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask MANÜ Telehealth which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Before you commit, get the ongoing monthly price of the medication itself, not a first-month rate, a membership fee or a per-vial price.
- MANÜ Telehealth serves all 50 states.
Contacting MANÜ Telehealth
- Phone
- +1 (786) 460-9055
- MANÜ Telehealth offers email support
Medications MANÜ Telehealth lists
MANÜ Telehealth lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides MANÜ Telehealth offers
MANÜ Telehealth sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
"Starting at $199" for both the standard and the micro-dose semaglutide plan. The homepage line "GLP-1s from $4/day" (about $120 a month) matches no listed plan.
"Starting at $297" for both the standard and the micro-dose tirzepatide plan. The homepage line "GLP-1s from $5/day" (about $150 a month) matches no listed plan.
Check the price yourself before you pay
Every figure here comes from MANÜ Telehealth's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to MANÜ Telehealth
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What MANÜ Telehealth charges
MANÜ Telehealth charges $199/month.
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $297/month
Belle Health, at about $199/month, is the closest like-for-like alternative we review.
What MANÜ Telehealth dispenses
MANÜ Telehealth prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
MANÜ Telehealth tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. We found no FDA warning letters issued to MANÜ Telehealth. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If MANÜ Telehealth will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
MANÜ Telehealth also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether MANÜ Telehealth bills your plan before you start.
It fits if
- you need access wherever you live
Our read
MANÜ Telehealth charges $199/month. Too few sellers offer the same drug and form to say whether that is cheap or expensive, so judge it on what the package includes.
The Bottom Line
MANÜ Telehealth scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $199 a month.
Before you pay MANÜ Telehealth
Starting at $199 a month. Check today's price, then start the intake.
Where MANÜ Telehealth is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to MANÜ Telehealth sets more sellers in the same category beside MANÜ Telehealth on price, states and what the price includes.
Frequently Asked Questions
How to check MANÜ Telehealth yourself
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Arizona, Arkansas, Delaware, Idaho, Louisiana, Maine, Michigan, New Jersey and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this MANÜ Telehealth review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See MANÜ Telehealth's current pricing
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.